Context: A 2009 Cochrane review concluded that thiazide antihypertensive drugs reduce the risk of death (RR 0.89), stroke (RR 0.63), coronary heart disease (RR 0.84), and cardiovascular events (RR 0.70) in people with high blood pressure. In the ensuring years other classes of antihypertensive drug were developed and found wide acceptance in combination therapy, including loop diuretics (Lasix/furosemide, Hoechst Pharmaceuticals, 1963), beta blockers (ICI Pharmaceuticals, 1964) ACE inhibitors, and angiotensin receptor blockers. ACE inhibitors reduce the risk of new onset kidney disease [RR 0.71] and death [RR 0.84] in diabetic patients, irrespective of whether they have hypertension.

Question: What do ACE inhibitors do?
Answer: reduce the risk of new onset kidney disease [RR 0.71] and death [RR 0.84] in diabetic patients

Question: What drugs reduce the risk of death and other events in people with high blood pressure?
Answer: thiazide antihypertensive drugs

Question: Who conducted the review on Thiazide Antihypertensive drugs?
Answer: Cochrane

Question: What were Thiazide Antihypertensive drugs used with?
Answer: combination therapy

Question: In what year did Cochrane release the report?
Answer: 2009

Question: What reduces the risk of new onset kidney diseases and death?
Answer: ACE inhibitors

Question: What type of drugs reduced the risk of strokes and heart disease for people with high blood pressure?
Answer: thiazide antihypertensive drugs

Question: In what year was thiazide antihypertensive drugs shown to help those with heart problems?
Answer: 2009

Question: What do RRE inhibitors do?
Answer: Unanswerable

Question: What drugs reduce the risk of death and other events in people with ACE?
Answer: Unanswerable

Question: Who conducted the review on RRE drugs?
Answer: Unanswerable

Question: What were RRE drugs used with?
Answer: Unanswerable

Question: In what year did ACE release the report?
Answer: Unanswerable